KR101744895B1 - 미라미스틴을 포함하는 약학적 제제 - Google Patents

미라미스틴을 포함하는 약학적 제제 Download PDF

Info

Publication number
KR101744895B1
KR101744895B1 KR1020127024396A KR20127024396A KR101744895B1 KR 101744895 B1 KR101744895 B1 KR 101744895B1 KR 1020127024396 A KR1020127024396 A KR 1020127024396A KR 20127024396 A KR20127024396 A KR 20127024396A KR 101744895 B1 KR101744895 B1 KR 101744895B1
Authority
KR
South Korea
Prior art keywords
propyl
myristoylamino
pharmaceutical
dimethyl
delete delete
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020127024396A
Other languages
English (en)
Korean (ko)
Other versions
KR20130018242A (ko
Inventor
아돌리나 루드코
Original Assignee
메가인팜 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 메가인팜 게엠베하 filed Critical 메가인팜 게엠베하
Publication of KR20130018242A publication Critical patent/KR20130018242A/ko
Application granted granted Critical
Publication of KR101744895B1 publication Critical patent/KR101744895B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020127024396A 2010-02-19 2011-02-15 미라미스틴을 포함하는 약학적 제제 Active KR101744895B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2010/001056 WO2011100994A1 (de) 2010-02-19 2010-02-19 Arzneimittel enthaltend myramistin
EPPCT/EP2010/001056 2010-02-19
PCT/EP2011/000691 WO2011101113A1 (de) 2010-02-19 2011-02-15 Arzneimittel enthaltend myramistin

Publications (2)

Publication Number Publication Date
KR20130018242A KR20130018242A (ko) 2013-02-20
KR101744895B1 true KR101744895B1 (ko) 2017-06-08

Family

ID=42668884

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127024396A Active KR101744895B1 (ko) 2010-02-19 2011-02-15 미라미스틴을 포함하는 약학적 제제

Country Status (20)

Country Link
EP (1) EP2536400B1 (enExample)
JP (1) JP5746224B2 (enExample)
KR (1) KR101744895B1 (enExample)
CN (1) CN102869354B (enExample)
AU (1) AU2011217530B2 (enExample)
BR (1) BR112012020828B1 (enExample)
CY (1) CY1115833T1 (enExample)
DK (1) DK2536400T3 (enExample)
EA (1) EA022283B1 (enExample)
ES (1) ES2524379T3 (enExample)
GE (1) GEP20135942B (enExample)
HR (1) HRP20141173T1 (enExample)
IL (1) IL221501A (enExample)
MD (1) MD4411C1 (enExample)
MX (1) MX2012009646A (enExample)
PL (1) PL2536400T3 (enExample)
PT (1) PT2536400E (enExample)
SI (1) SI2536400T1 (enExample)
UA (1) UA103968C2 (enExample)
WO (2) WO2011100994A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014175757A1 (ru) * 2013-04-22 2014-10-30 Общество с ограниченной ответственностью "Нанобиотех" Антисептический ветеринарный препарат и способы его использования
RU2542376C1 (ru) * 2013-07-30 2015-02-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек
CN109456218A (zh) * 2018-12-17 2019-03-12 山东诚汇双达药业有限公司 一种盐酸三甲卡因的生产方法
GB202003240D0 (en) * 2020-03-05 2020-04-22 Ecosynth Nv Antiviral treatment

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000892A1 (fr) 1991-07-10 1993-01-21 Jury Semenovich Krivoshein Preparation pharmaceutique
US20040033208A1 (en) * 2000-12-20 2004-02-19 Cagle Gerald D. Antifungal compositions containing an antibiotic and one or more amidoamines
WO2006075932A2 (en) * 2005-01-13 2006-07-20 Otkrytoe Akzionernoe Obschestvo 'sistema Venture' Remedy to accelerate healing of wound and burn

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2459062A (en) 1944-02-08 1949-01-11 American Cyanamid Co Quaternary ammonium compounds
US4093711A (en) * 1976-08-13 1978-06-06 Noxell Corporation Oral hygiene
SU1796185A1 (ru) 1990-06-23 1993-02-23 Adolina P Rudko Фунгицид 2
US5393491A (en) 1993-09-22 1995-02-28 Alcon Laboratories, Inc. Use of amidoamines in ophthalmic compositions
UA30143C2 (uk) * 1997-12-30 2001-11-15 Юрій Семенович Кривошеін Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань
RU2157214C2 (ru) 1998-04-16 2000-10-10 Государственный научный центр лекарственных средств Противовоспалительное и антимикробное лекарственное средство для местного применения
RU2161961C1 (ru) * 2000-03-17 2001-01-20 Кривошеин Юрий Семенович Лекарственный препарат
RU2177314C2 (ru) 2000-03-22 2001-12-27 Кривошеин Юрий Семенович Состав с антисептическими, репаративными и болеутоляющими свойствами
RU2173142C1 (ru) 2000-04-18 2001-09-10 Кривошеин Юрий Семенович Вагинальный контрацептив
RU2164135C1 (ru) * 2000-04-27 2001-03-20 Рудько Адолина Петровна Глазной антисептик
RU2184534C2 (ru) 2000-04-27 2002-07-10 Рудько Адолина Петровна Антисептические таблетки
RU2185156C2 (ru) 2000-06-26 2002-07-20 Рудько Адолина Петровна Интраназальный антисептик
RU2185157C2 (ru) 2000-06-26 2002-07-20 Рудько Адолина Петровна Средство для лечения ожоговых ран
RU2188005C2 (ru) 2000-10-04 2002-08-27 Рудько Адолина Петровна Состав для антисептической обработки кожи рук и операционного поля
WO2002049627A2 (en) * 2000-12-20 2002-06-27 Alcon, Inc. Antifungal compositions containing an antibiotic and one or more amidoamines
WO2002049633A2 (en) 2000-12-20 2002-06-27 Alcon, Inc. Use of amidoamines to treat or prevent acanthamoeba and fungal infections
RU2234313C1 (ru) 2003-06-04 2004-08-20 Кривошеин Юрий Семенович Средство инактивации коронавирусов
US20070264226A1 (en) 2006-05-10 2007-11-15 Karagoezian Hampar L Synergistically enhanced disinfecting solutions
CN101562971A (zh) * 2006-05-10 2009-10-21 S.K.药物公司 协同增强的消毒溶液
CN101100432B (zh) * 2006-07-04 2010-08-04 中国人民解放军军事医学科学院毒物药物研究所 苯甲基二甲基[3-(肉豆蔻酰胺基)丙基]氯化铵的合成方法
DE102008039234A1 (de) * 2007-10-29 2009-05-07 Neudecker & Jolitz Gmbh & Co. Motorisch betriebener Türöffner und Motor für einen Türöffner
UA30143U (en) 2007-11-14 2008-02-11 Валерий Михайлович Шарапов Piezoelectric transformer
DE102008039254A1 (de) * 2008-08-20 2010-02-25 Megainpharm Gmbh Arzneimittel

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000892A1 (fr) 1991-07-10 1993-01-21 Jury Semenovich Krivoshein Preparation pharmaceutique
US20040033208A1 (en) * 2000-12-20 2004-02-19 Cagle Gerald D. Antifungal compositions containing an antibiotic and one or more amidoamines
WO2006075932A2 (en) * 2005-01-13 2006-07-20 Otkrytoe Akzionernoe Obschestvo 'sistema Venture' Remedy to accelerate healing of wound and burn

Also Published As

Publication number Publication date
EP2536400A1 (de) 2012-12-26
CY1115833T1 (el) 2017-01-25
GEP20135942B (en) 2013-10-10
ES2524379T3 (es) 2014-12-05
JP5746224B2 (ja) 2015-07-08
BR112012020828B1 (pt) 2021-01-12
JP2013519695A (ja) 2013-05-30
WO2011101113A1 (de) 2011-08-25
MX2012009646A (es) 2013-02-11
EP2536400B1 (de) 2014-09-24
PT2536400E (pt) 2014-11-27
AU2011217530B2 (en) 2014-01-16
WO2011100994A1 (de) 2011-08-25
BR112012020828A2 (pt) 2016-06-28
DK2536400T3 (en) 2014-12-15
KR20130018242A (ko) 2013-02-20
HK1179164A1 (zh) 2013-09-27
CN102869354A (zh) 2013-01-09
PL2536400T3 (pl) 2015-04-30
MD20120079A2 (en) 2013-01-31
EA022283B1 (ru) 2015-12-30
MD4411B1 (ro) 2016-04-30
HRP20141173T1 (hr) 2015-01-30
UA103968C2 (ru) 2013-12-10
AU2011217530A1 (en) 2012-09-13
SI2536400T1 (sl) 2015-01-30
CN102869354B (zh) 2015-12-16
EA201201158A1 (ru) 2013-02-28
IL221501A (en) 2016-11-30
MD4411C1 (ro) 2016-11-30

Similar Documents

Publication Publication Date Title
US8426474B2 (en) Antimicrobial wash and carrier solutions and uses thereof
JP3777499B2 (ja) 抗真菌組成物
JP2012229221A (ja) 半固形製剤中でのオクテニジン二塩酸塩の使用
CN1946428A (zh) 具有治疗作用的抗微生物组合物和方法
RU2370265C1 (ru) Гель, обладающий противовоспалительным и противоаллергическим действием
US4873265A (en) Anti-infective methods and compositions
KR20190126302A (ko) 키토산-함유 제제 및 그의 제조 및 사용 방법
HK1243354B (zh) 新颖碘伏组合物及其使用方法
WO2008035243A2 (en) Composition for treatment of burns and wounds
KR20130018242A (ko) 미라미스틴을 포함하는 약학적 제제
CN108420789A (zh) 一种苯扎氯铵外用溶液及其制备方法
US20100099704A1 (en) Lotion Preparation Containing Pyridonecarboxylic Acid Derivative
JPH01163126A (ja) 少なくとも１種の単細胞生物を阻害し，又は破壊する，弗素Ｆ↑−及びリチウムＬｉ↑＋を含む組成物
HK1179164B (en) Pharmaceutical comprising myramistin
US4897404A (en) Anti-infective methods and compositions
US4895859A (en) Anti-infective methods and compositions
KR20240069356A (ko) 질 칸디다증 치료용 스프레이 약학적 조성물
US4895857A (en) Anti-infective methods and compositions
DE102008039254A1 (de) Arzneimittel
RU2687745C1 (ru) Комбинированное лекарственное средство в виде раствора для получения спрея для лечения заболеваний ротовой полости
JPH01283217A (ja) 皮膚疾患治療剤
HK1043739A1 (en) Use of a pharmaceutical composition in the manufacture of a medicament for the treatment of pathological conditions of the eye caused by bacteria, viruses, fungi, yeasts and protozoa
HK1043739B (en) Use of a pharmaceutical composition in the manufacture of a medicament for the treatment of pathological conditions of the eye caused by bacteria, viruses, fungi, yeasts and protozoa
EA041271B1 (ru) Противозачаточная микробицидная композиция и способ предупреждения заболеваний, передающихся половым путем

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R15-X000 Change to inventor requested

St.27 status event code: A-3-3-R10-R15-oth-X000

R16-X000 Change to inventor recorded

St.27 status event code: A-3-3-R10-R16-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 9